Landscape Capital Management L.L.C. Increases Stake in CVS Health Co. (NYSE:CVS)

Landscape Capital Management L.L.C. boosted its stake in CVS Health Co. (NYSE:CVS) by 55.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 117,729 shares of the pharmacy operator’s stock after purchasing an additional 42,205 shares during the quarter. CVS Health comprises 0.6% of Landscape Capital Management L.L.C.’s portfolio, making the stock its 20th largest position. Landscape Capital Management L.L.C.’s holdings in CVS Health were worth $5,285,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Ridgewood Investments LLC increased its holdings in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the last quarter. Stonebridge Financial Group LLC acquired a new stake in CVS Health during the fourth quarter worth about $28,000. Hopwood Financial Services Inc. purchased a new position in shares of CVS Health in the 4th quarter worth about $29,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Finally, Financial Perspectives Inc increased its position in CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock worth $36,000 after purchasing an additional 466 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.9 %

Shares of NYSE CVS opened at $67.44 on Friday. The stock has a market capitalization of $85.03 billion, a P/E ratio of 18.43, a PEG ratio of 0.98 and a beta of 0.54. The stock’s 50 day moving average price is $63.29 and its two-hundred day moving average price is $57.97. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $75.27.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 3.94%. CVS Health’s dividend payout ratio (DPR) is 72.68%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Wolfe Research lifted their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research report on Tuesday, February 11th. Wells Fargo & Company upped their target price on CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Finally, StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $70.39.

Insider Buying and Selling at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the firm’s stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the purchase, the director now owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.